TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+10.4%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$3.08B
AUM Growth
+$3.08B
(+5.9%)
Cap. Flow
-$52.2M
Cap. Flow
% of AUM
-1.7%
Top 10 Holdings %
Top 10 Hldgs %
31.64%
Holding
198
New
2
Increased
42
Reduced
40
Closed
9
Top Buys
| 1 |
UnitedHealth
UNH
|
$41.4M |
| 2 |
Health Care Select Sector SPDR Fund
XLV
|
$22.5M |
| 3 |
United Therapeutics
UTHR
|
$13.6M |
| 4 |
Thermo Fisher Scientific
TMO
|
$13.4M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$11.7M |
Top Sells
| 1 |
Elevance Health
ELV
|
$21.8M |
| 2 |
Illumina
ILMN
|
$21.3M |
| 3 |
Steris
STE
|
$20.4M |
| 4 |
Waters Corp
WAT
|
$18.8M |
| 5 |
Bristol-Myers Squibb
BMY
|
$15.8M |
Sector Composition
| 1 | Healthcare | 95.67% |
| 2 | Real Estate | 2.94% |
| 3 | Industrials | 0.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
McKesson
MCK
$85.9B
| $28.8M | 0.94% |
150,715
+24,767
| +20% | +$4.74M |
|
27
AstraZeneca
AZN
$255B
| $26.9M | 0.87% |
448,298
+103,965
| +30% | +$6.23M |
|
28
CRISPR Therapeutics
CRSP
$4.82B
| $26.3M | 0.85% |
162,337
+11,379
| +8% | +$1.84M |
|
29
HCA Healthcare
HCA
$95.4B
| $25.8M | 0.84% |
124,743
-28,154
| -18% | -$5.82M |
|
30
Humana
HUM
$37.5B
| $25.7M | 0.84% |
58,135
+20,794
| +56% | +$9.21M |
|
|
31
United Therapeutics
UTHR
$17.7B
| $25M | 0.81% |
139,438
+75,925
| +120% | +$13.6M |
|
32
Exact Sciences
EXAS
$9.33B
| $24.8M | 0.81% |
199,654
+32,352
| +19% | +$4.02M |
|
33
Dentsply Sirona
XRAY
$2.77B
| $24.2M | 0.79% |
382,344
+30,917
| +9% | +$1.96M |
|
|
34
Health Care Select Sector SPDR Fund
XLV
$33.8B
| $23.8M | 0.77% |
188,930
+178,875
| +1,779% | +$22.5M |
|
35
Edwards Lifesciences
EW
$47.7B
| $22.9M | 0.75% |
221,555
-17,200
| -7% | -$1.78M |
|
36
Alnylam Pharmaceuticals
ALNY
$58.6B
| $22.8M | 0.74% |
134,495
-20,407
| -13% | -$3.46M |
|
37
argenx
ARGX
$44.2B
| $22.4M | 0.73% |
74,410
+10,066
| +16% | +$3.03M |
|
38
Idexx Laboratories
IDXX
$50.7B
| $22M | 0.71% |
34,814
| – | – |
|
|
SYNH
39
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $21.8M | 0.71% |
243,633
-29,014
| -11% | -$2.6M |
|
40
Neurocrine Biosciences
NBIX
$13.5B
| $20.7M | 0.67% |
212,891
| – | – |
|
41
Charles River Laboratories
CRL
$7.99B
| $20.2M | 0.66% |
54,674
+11,600
| +27% | +$4.29M |
|
42
Ascendis Pharma
ASND
$12.1B
| $20.2M | 0.66% |
153,636
+35,300
| +30% | +$4.64M |
|
43
Guardant Health
GH
$8.11B
| $19.7M | 0.64% |
158,727
| – | – |
|
44
Intuitive Surgical
ISRG
$158B
| $19.6M | 0.64% |
63,888
| – | – |
|
45
Labcorp
LH
$22.8B
| $19.4M | 0.63% |
81,915
-33,996
| -29% | -$8.06M |
|
46
Novavax
NVAX
$1.2B
| $18.6M | 0.6% |
87,596
-17,580
| -17% | -$3.73M |
|
47
Pfizer
PFE
$141B
| $17.6M | 0.57% |
450,379
-254,880
| -36% | -$9.98M |
|
48
Welltower
WELL
$112B
| $16.9M | 0.55% |
203,083
| – | – |
|
|
49
Waters Corp
WAT
$17.3B
| $16.7M | 0.54% |
48,306
-54,404
| -53% | -$18.8M |
|
50
Molina Healthcare
MOH
$9.6B
| $16.1M | 0.52% |
63,610
+23,841
| +60% | +$6.03M |
|